Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
99.79
+1.39 (1.41%)
At close: Mar 9, 2026, 4:00 PM EDT
98.00
-1.79 (-1.79%)
After-hours: Mar 9, 2026, 6:59 PM EDT
Revolution Medicines Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 19,776 | 15,398 | 8,083 | 4,720 | 2,115 | 1,855 | |
| Market Cap Growth | 153.23% | 90.50% | 71.26% | 123.15% | 14.03% | -29.43% | |
| Enterprise Value | 18,177 | 13,881 | 6,620 | 3,969 | 1,525 | 1,278 | |
| Last Close Price | 99.79 | 79.65 | 43.74 | 28.68 | 23.82 | 25.17 | |
| PS Ratio | - | - | - | 407.58 | 59.78 | 63.11 | |
| PB Ratio | 12.05 | 9.44 | 3.57 | 2.58 | 3.09 | 3.08 | |
| P/TBV Ratio | 12.67 | 9.87 | 3.68 | 2.69 | 3.46 | 3.51 | |
| EV/Sales Ratio | - | - | - | 342.78 | 43.11 | 43.48 | |
| Debt / Equity Ratio | 0.26 | 0.26 | 0.06 | 0.05 | 0.09 | 0.11 | |
| Net Debt / Equity Ratio | -0.98 | -0.98 | -0.95 | -0.97 | -0.85 | -0.85 | |
| Net Debt / EBITDA Ratio | 1.36 | 1.36 | 3.15 | 3.66 | 2.28 | 2.76 | |
| Net Debt / FCF Ratio | 1.75 | 1.75 | 3.79 | 4.93 | 2.47 | 3.32 | |
| Asset Turnover | - | - | - | 0.01 | 0.05 | 0.05 | |
| Quick Ratio | 6.98 | 6.98 | 13.97 | 12.89 | 10.48 | 9.66 | |
| Current Ratio | 7.15 | 7.15 | 14.20 | 13.06 | 10.65 | 9.77 | |
| Return on Equity (ROE) | -58.07% | -58.07% | -29.33% | -34.75% | -38.63% | -34.73% | |
| Return on Assets (ROA) | -30.08% | -30.08% | -18.66% | -21.19% | -20.83% | -18.00% | |
| Return on Capital Employed (ROCE) | -57.30% | -57.30% | -28.80% | -25.40% | -34.40% | -27.70% | |
| Earnings Yield | -5.72% | -7.35% | -7.42% | -9.25% | -11.76% | -10.09% | |
| FCF Yield | -4.62% | -5.93% | -7.02% | -7.59% | -11.12% | -8.29% | |
| Buyback Yield / Dilution | -13.35% | -13.35% | -48.24% | -40.34% | -10.74% | -32.68% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.